David A. Sclar, BPharm, PhD | Psychiatrist.com

Letter to the Editor

Quantifying Gabapentin Misuse With Opioids

March 14, 2019

This letter to the editor explores predictive models related to combined misuse of gabapentin and opioids. Read on to find out more about this important public health topic.

David A. Sclar, Alyssa M. Peckham

Brief Report

Selegiline Transdermal System: Use Pattern and Adherence in Patients With Major Depressive Disorder

February 21, 2013

Since adherence and health outcomes are strongly associated, Sclar and colleagues conducted a retrospective exploratory claims-based analysis to discern the pattern of use of selegiline transdermal system relative to...

Lawrence J. Cohen, David A. Sclar, Kimberly Blanchard Portland

Educational Activity

MAOIs: Issues in Treatment Adherence and Rates of Treatment Failure

January 15, 2013

Lawrence J. Cohen, David A. Sclar

Supplement Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

Michael E. Thase, Larry Culpepper, Robert M. A. Hirschfeld, et al

Supplement Article

Introduction: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 27, 2012

Lawrence J. Cohen, David A. Sclar

Supplement Article

Issues in Adherence to Treatment With Monoamine Oxidase Inhibitors and the Rate of Treatment Failure

July 27, 2012

Lawrence J. Cohen, David A. Sclar

Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 15, 2012

Michael E. Thase, Larry Culpepper, Robert M. A. Hirschfeld, et al

Article

Introduction: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

July 15, 2012

Lawrence J. Cohen, David A. Sclar

Article

Issues in Adherence to Treatment With Monoamine Oxidase Inhibitors and the Rate of Treatment Failure

July 15, 2012

Lawrence J. Cohen, David A. Sclar

Article

Hospital Admission for Schizophrenia and Discharge Against Medical Advice in the United States

March 11, 2010

The objective of this study was to determine the prevalence of and predictive factors for being discharged against medical advice among hospitalized patients with schizophrenia.

David A. Sclar, Linda M. Robison

Original Research

Coverage of Atypical Antipsychotics Among Medicare Drug Plans in the State of Washington for Fiscal Year 2007

August 15, 2008

Lawrence J. Cohen, David A. Sclar, Chi-Chuan Wang, et al

Article

Economic Outcomes With Antidepressant Pharmacotherapy: A Retrospective Intent-To-Treat Analysis

March 1, 1998

David A. Sclar, Tracy L. Skaer, Linda M. Robison, et al